Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Therapy for pediatric myocarditis.

Charles E Canter1

  • 1Department of Pediatrics, Division of Cardiology, Washington University School of Medicine, St. Louis, MO 63110, USA. canter@kids.wustl.edu

Current Treatment Options in Cardiovascular Medicine
|September 6, 2005
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Psychosocial and Functional Outcomes Among Tetralogy of Fallot Survivors in the Congenital Heart Disease Project to Understand Lifelong Survivor Experience.

The American journal of cardiology·2026
Same author

Contemporary approach to desensitization: Targeted therapies for HLA sensitized pediatric heart transplant candidates - Study design and rationale.

JHLT open·2026
Same author

Reproductive health outcomes of congenital heart disease survivors: A report from the congenital heart disease project to understand lifelong survivor experience (CHD PULSE study).

American heart journal·2026
Same author

Cardiomyopathy-Associated Pathogenic Variants in Pediatric Myocarditis: A Study From the Pediatric Cardiomyopathy Registry.

Circulation. Heart failure·2025
Same author

Rationale and design of CHD PULSE: Congenital Heart Disease Project to Understand Lifelong Survivor Experience.

American heart journal·2024
Same author

Quality of Life and Exercise Capacity in Early Stage and Subclinical Hypertrophic Cardiomyopathy: A Secondary Analysis of the VANISH Trial.

Circulation. Heart failure·2024
Same journal

An Update on the Role of Renal Artery Denervation in the Treatment of Hypertension.

Current treatment options in cardiovascular medicine·2026
Same journal

Advancements and Challenges in Contemporizing Care for Adult Patients with Congenital Heart Disease and Advanced Heart Failure: An Update on Application of Modern Heart Failure Technologies.

Current treatment options in cardiovascular medicine·2026
Same journal

Evolving Decongestion Strategies in the Management of Acute Heart Failure.

Current treatment options in cardiovascular medicine·2025
Same journal

Advanced Electroanatomic Mapping: Current and Emerging Approaches.

Current treatment options in cardiovascular medicine·2025
Same journal

Metabolic Reprogramming in Heart Failure: From Energy Starvation to Therapeutic Targets.

Current treatment options in cardiovascular medicine·2025
Same journal

Drug-Coated Balloons for Coronary Artery Disease: From Theory to Practice.

Current treatment options in cardiovascular medicine·2025
See all related articles

Pediatric myocarditis, often causing congestive heart failure in children, requires aggressive supportive care, especially for severe cases. While some therapies show promise, their routine use is debated due to spontaneous recovery and lack of proven benefit in rigorous trials.

Area of Science:

  • Pediatric Cardiology
  • Cardiovascular Pathology
  • Critical Care Medicine

Background:

  • Pediatric myocarditis frequently presents as acute or subacute congestive heart failure in healthy children.
  • Fulminant myocarditis, a severe form, demonstrates a high recovery rate with intensive supportive care, including mechanical circulatory support.
  • Subacute heart failure management in pediatric myocarditis primarily relies on supportive care.

Purpose of the Study:

  • To review the current understanding and therapeutic approaches for pediatric myocarditis.
  • To evaluate the safety and efficacy of immunosuppressive and immunomodulating therapies in pediatric myocarditis.
  • To discuss the challenges in translating findings from uncontrolled pediatric studies to routine clinical practice.

Main Methods:

Related Experiment Videos

  • Review of existing pediatric studies on myocarditis treatment.
  • Analysis of data regarding supportive care, immunosuppressive therapy, and intravenous gamma globulin.
  • Consideration of evidence from adult myocarditis trials regarding immunosuppressive therapies.

Main Results:

  • Uncontrolled pediatric studies suggest immunosuppressive and immunomodulating therapies may be safe and beneficial.
  • High rates of spontaneous improvement in myocarditis with supportive care complicate treatment evaluation.
  • Blinded, randomized, placebo-controlled trials in adults have not demonstrated clear benefits for these therapies.

Conclusions:

  • Aggressive supportive care, including mechanical support for fulminant cases, is crucial for pediatric myocarditis.
  • The role of immunosuppressive and immunomodulating therapies in routine pediatric myocarditis treatment remains uncertain.
  • Heart transplantation is reserved for children with myocarditis and intractable severe heart failure.